For more than three decades various forms of robotics have been effectively applied in healthcare to advance different types of medical treatment and surgical processes. Now, the nation’s first robotic positioning arm for proton therapy is being used by Loma Linda University Medical Center (LLUMC) to provide physicians improved access to tumors typically regarded as difficult to reach and treat.

Breast Tomosynthesis 3-D Mammography Hologic

Hologic Inc. announced the results of an independent survey by KLAS Research of Hologic 3-D mammography sites in the United States. The in-depth survey, which was not commissioned by Hologic, included fifty respondents whose facilities had used Hologic's 3-D mammography (breast tomosynthesis) technology for at least one year. The researcher reported that "providers are seeing cancers that they would not previously have seen with traditional digital mammography," and concluded that providers who are considering 3-D mammography "would benefit by quickly jumping on the bandwagon."

EOS imaging announced that its next-generation sterEOS 3-D imaging software, sterEOS 1.5, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The sterEOS 1.5 software was highlighted along with the full EOS Imaging System at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, March 19-23 in Chicago, Ill. The technology is also featured in a paper submitted for the Hip Society Awards, which was presented on Saturday, March 23.

 

Computed Tomography (CT) Colonography Screening Colorectal Cancer

As Americans celebrate National Colorectal Cancer Awareness Month (March), the Colon Cancer Alliance, Colontown — a survivor/patient support group for colorectal disease, including cancer — and the American College of Radiology (ACR) call on Congress to pass the Computed Tomography (CT) Colonography Screening for Colorectal Cancer Act (H.R. 991). Introduced recently by Reps. Ralph Hall (TX-04) and Danny Davis (D-IL), H.R. 991 would require Medicare to cover beneficiaries for CT colonography — otherwise known as virtual colonoscopy.

Fujifilm SonoSite Inc. announced the launch of AxoTrack Needle Guidance Technology on select SonoSite Ultrasound Systems. This newly developed product, named by Popular Science Magazine as one of 2012’s best new innovations, is now available for use with SonoSite M-Turbo Ultrasound Systems.

AxoTrack Needle Guidance Technology

The American College of Radiology (ACR) has affirmed its support for the Diagnostic Imaging Services Access Protection Act (S. 623) recently introduced in the Senate by Senators Ben Cardin (D-MD) and David Vitter (R-LA).

Piramal Imaging SA, a division of Piramal Enterprises, announced that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted its applications for review of the investigational positron emission tomography (PET) amyloid imaging agent [18F] florbetaben. A New Drug Application (NDA) was submitted to the FDA and a Marketing Authorization Application to the EMA for [18F] florbetaben use in the visual detection of beta-amyloid in the brains of adults with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive decline. [18F] florbetaben binds to beta-amyloid plaques in the human brain, a hallmark characteristic in Alzheimer's disease.

 

FujiFilm Medical Systems U.S.A. Inc. showcased its Synapse 3D at the American College of Cardiology (ACC) conference March 9 to 11, 2013 at the Moscone Center in San Francisco, Calif. Fully integrated with Synapse Cardiovascular, Synapse 3D will appeal to cardiologists and cardiovascular specialists interested in advanced visualization and analysis for their diagnostic needs.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now